Over the past decades, electronics and biomedical engineers have developed increasingly sophisticated biosensors, devices ...

Ischemic cardiomyopathy changes how the heart pumps blood because of muscle damage. Learn about the role of medication in ...

If you use a continuous glucose monitoring ... assess heart disease and fatty liver—conditions commonly linked with diabetes.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Exposure to extreme heat may double or triple the risk of irregular heart rhythms in people with implanted defibrillators, new research suggests.

Severe temperature spikes may double or triple the risk of irregular heart rhythm in people with implanted defibrillators. An analysis of health data for more than 2,000 people with implantable ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...

Transforming patient care, medical sensors enable continuous monitoring and early detection, paving the way for personalized ...

Researchers used an electrophysiological computer model of the heart's electrical circuits to examine the effect of the applied voltage field in multiple fibrillation-defibrillation scenarios. They ...

Spurred by advances in energy-harvesting materials, a new generation of advanced implantable biomedical devices is emerging ...

Medically reviewed by Christopher Lee, MD Systolic congestive heart failure, or systolic heart failure, is a type of heart ...